| S.No. | Ticker | Company | Market Cap | P/E | P/S | ROCE (TTM) | Div Yield % | Total Debt (TTM) | Int Coverage (TTM) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | LLY | ELI LILLY & Co | 1,096.48 Bn | 444.66 | 53.21 | 33.31% | 0.36% | 42.50 Bn | 0.00 |
| 2 | JNJ | Johnson & Johnson | 586.00 Bn | 21.86 | 6.22 | 23.13% | 2.11% | 47.93 Bn | 34.55 |
| 3 | MRK | Merck & Co., Inc. | 351.73 Bn | 29.51 | 8.33 | 22.87% | 2.16% | 41.37 Bn | 18.13 |
| 4 | ABBV | AbbVie Inc. | 346.46 Bn | 41.07 | 10.17 | 4.48% | 2.68% | 68.74 Bn | 1.64 |
| 5 | AZN | Astrazeneca Plc | 324.54 Bn | 31.74 | 5.53 | 16.89% | 1.99% | 29.62 Bn | 8.28 |
| 6 | NVS | Novartis Ag | 322.29 Bn | 23.05 | 5.69 | 20.93% | 2.33% | 35.46 Bn | 15.31 |
| 7 | GILD | Gilead Sciences, Inc. | 237.69 Bn | 78.03 | 22.28 | 23.59% | 0.51% | 24.94 Bn | 10.70 |
| 8 | AMGN | Amgen Inc | 233.95 Bn | 29.40 | 9.93 | 18.02% | 2.16% | 54.60 Bn | 4.26 |
| 9 | NVO | Novo Nordisk A S | 219.30 Bn | 13.62 | 4.51 | 39.89% | 3.4% | 20.59 Bn | 0.00 |
| 10 | PFE | Pfizer Inc | 152.21 Bn | 19.69 | 4.75 | 5.31% | 8.44% | 61.71 Bn | 0.00 |
| 11 | GSK | GSK plc | 123.29 Bn | 15.96 | 2.79 | 18.95% | 2.74% | 23.95 Bn | 10.74 |
| 12 | BMY | Bristol Myers Squibb Co | 120.32 Bn | 22.11 | 7.24 | 14.0% | 3.1% | 45.11 Bn | 0.00 |
| 13 | SNY | Sanofi | 113.36 Bn | 12.33 | 2.06 | 9.57% | 4.76% | 23.92 Bn | 16.73 |
| 14 | BIIB | Biogen Inc. | 28.64 Bn | 22.15 | 2.90 | 5.97% | 0.0% | 6.58 Bn | 0.00 |
| 15 | OGN | Organon & Co. | 1.85 Bn | 3.17 | 0.30 | 11.19% | 15.66% | 8.83 Bn | 2.36 |
| 16 | SCLX | Scilex Holding Co | 0.10 Bn | -0.25 | 2.36 | 389.82% | 0.0% | 0.07 Bn | -39.27 |
| 17 | MIRA | Mira Pharmaceuticals, Inc. | 0.02 Bn | -0.48 | 0.00 | -74.14% | 0.0% | 0.00 Bn | 0.00 |
| 18 | MDCX | Medicus Pharma Ltd. | 0.02 Bn | -0.51 | 0.00 | 4357.13% | 0.0% | 0.01 Bn | 283.47 |
| 19 | AMRN | Amarin Corp Plc\Uk | 0.00 Bn | 0.00 | 0.00 | - | 0.0% | - | - |
| 20 | GRFS | Grifols SA | 0.00 Bn | 0.00 | 0.00 | - | 0.0% | - | - |